MedPath

Buprenorphine Detox With Two Types of Treatment. BBD II - 11

Phase 2
Completed
Conditions
Opioid-Related Disorders
Registration Number
NCT00000229
Lead Sponsor
University of Vermont
Brief Summary

The purpose of this study is to compare overall treatment outcome between behavioral versus enhanced behavioral treatment types.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Drug use
Weeks abstinent
Retention
Weeks continuous abstinence
Overall treatment outcome
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Treatment Research Center

🇺🇸

Burlington, Vermont, United States

© Copyright 2025. All Rights Reserved by MedPath